𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease

✍ Scribed by P. Barone; L. Scarzella; R. Marconi; A. Antonini; L. Morgante; F. Bracco; M. Zappia; B. Musch; and the Depression/Parkinson Italian Study Group

Publisher
Springer
Year
2006
Tongue
English
Weight
310 KB
Volume
253
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sertraline for the treatment of depressi
Sertraline for the treatment of depression in parkinson's disease
✍ Dr. Robert A. Hauser; Theresa A. Zesiewicz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

## Abstract Although antidepressant medications are commonly used to treat depression in Parkinson's disease (PD), little information is available regarding their safety and efficacy in this condition. Sertraline is a relatively selective serotonin reuptake inhibitor with some dopamine reuptake inh

Increase in body weight after pramipexol
Increase in body weight after pramipexole treatment in Parkinson's disease
✍ Hatice Kumru; Joan Santamaria; Francesc Valldeoriola; Maria J. Marti; Eduardo To 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract Body weight changes occur during the clinical course of Parkinson's disease (PD) and with surgical treatment, but the effect of dopaminergic treatment on weight is unknown. Body mass index (BMI), Hamilton depression scale score (HDS), and Unified Parkinson's Disease Rating Scale III (UP